Forums >Off the Beaten Path>Generic Prescript. costs = Name Brand...huh?
At least for now...it took over 2 years for another steady generic manufacturer to hit the market with Protonix, so don't hold your breath!
There's one I know.
Generic pharma companies either manufacture the med or contract out its manufacture. If Watson could do it in-house, they would ... so either (a) they can't duplicate Concerta's particular efficacy profile (i.e., can't make a truly generic Conerta) or (b) it's less costly in the long run for them to contract out to J&J to have it made.
And speak of the devil:
Watson announced that it has launched generic Concerta via its Watson Laboratories Inc. Concerta is the brand name for methylphenidate hydrochloride extended release tablet which has been approve as treatment of attention deficit hyperactivity disorder in children whose age range from 6 to 7 and in adults whose age range from 18 to 65. Concerta is to be used in conjunction with other treatment program such as counseling or other therapies. The launch was expected as it was part of the exclusive agreement that Watson has signed with Ortho-McNeil-Janssen Pharmaceuticals in November 2010. Under the term of the agreement, Watson is allowed to market generic Conerta while OMJP will manufacture and be a sole supplier of Watson's generic Concerta for the following dosages: 18 mg, 27 mg, 36 mg and 54 mg. The agreement is to last until the end of 2014. OMJP will be entitled to receive the net sales from the product. Under the term of the agreement, Watson is free to file an ANDA for Concerta during the time in which the exclusive agreement remains effective (which is until the end of 2014). After which, Watson is free to launch its own generic Concerta. In 2004, OMJP has filed a Citizen Petition to request all generic version of Concerta to demonstrate similar onset of efficacy and duration of effective compared to the branded Concerta. The FDA is currently reviewing the petition but it is not to impact the launch of Watson's Generic Concerta.
MTA: There were two US patents to Concerta. Only one was invalidated. (Invalidity was affirmed by the appellate court in April 2010, but OMJP petitioned to the Supreme Court. I didn't see what the ultimate outcome was.) So there's still a valid US patent on Concerta.
"I want you to pray as if everything depends on it, but I want you to prepare yourself as if everything depends on you."
-- Dick LeBeau
rectumdamnnearkilledem
So...if I read that right, we can expect to pay full price through 2014...so generic really isn't generic, at this point.
Getting the wind knocked out of you is the only way to
remind your lungs how much they like the taste of air.
~ Sarah Kay
Feeling the growl again
They are not free. Your patients are paying for them. We don't get those either.
They are not free. Your patients are paying for them.
We don't get those either.
"If you want to be a bad a$s, then do what a bad a$s does. There's your pep talk for today. Go Run." -- Slo_Hand
I am spaniel - Crusher of Treadmills
Good Bad & The Monkey
Money's gotta come from somewhere...
I'm running somewhere tomorrow. It's going to be beautiful. I can't wait.
Poor baby
Lunches fall under SG&A and are not part of the cost of goods sold, so do not directly affect the price of the product--obviously at some level overhead has an impact on prices, eventually, but the connection is not always clear. Since the purpose of the lunches is to influence sales, lowering entertainment expenses (which lunches fall under) will also result in lower sales, theoretically. You could argue that getting rid of lunches and schwag might actually cause the per-unit price of a drug to go up, not down.
Runners run
Well, except that very often, the medications being hocked via lunches and golf tours are the new pricey ones that are not proven to be any better in the real world than the existing, less expensive drugs. If I prescribe levaquin for a strep infection, the patient is not going to get any more better than if I prescribe amoxicillin. But the levaquin will cost some 23 times more to the patient (and the healthcare system). There is a levaquin rep. There is not an amox rep.
Well now you're comparing the price of two different products.
Bottom line is the only way to fix healthcare is with nukes.
True. A big part of the lunches is to get folks to be irrational and choose the more expensive of two equal products.
True.
True. A big part of the lunches is to get folks to be irrational and choose the more expensive of two equal products. True.
I'm not saying there's nothing wrong with it, but since I can't prescribe anything yet, I eat guilt-free.
But on a more serious note, I don't see this in this hospitals, just in the private primary care offices. Those doctors are also the ones who keep their (usually uninsured) patients supplied with free samples from the pharm reps so that they don't have to buy any meds. It's a strange circle. It ain't right, but it's how a lot of healthcare is done here where the unemployment/uninsured rates are sky-high. No wonder everyone is so jaded...
But anyhow, i'm DONNNNEEE with MD1!
i think i'll go for a run.
In most cases your assumption that selling expenses are part of the equation here is incorrect.
The money to pay for lunches and golf trips has to come from somewhere.
Whether eliminating that cost will reduce drug prices is a different question.
SMART Approach
.......Since the purpose of the lunches is to influence sales
The purpose is to educate docs and nursing staff on new studies, indications, new contraindications, pipeline, differentiate from the competitors. They are very valuable to docs
Run Coach. Recovery Coach. Founder of SMART Approach Training, Coaching & Recovery
Structured Marathon Adaptive Recovery Training
Safe Muscle Activation Recovery Technique
www.smartapproachtraining.com
The money to pay for lunches and golf trips has to come from somewhere. Whether eliminating that cost will reduce drug prices is a different question.